At Creative Biolabs, we are committed to advancing therapeutic antibody and protein development by offering a wide array of bioassays. Cell proliferation assays are essential tools in drug discovery and development that help elucidate the efficacy and potency of therapeutic agents. Leveraging advanced assay technologies and a wealth of expertise, our team of experienced scientists offers a comprehensive suite of cell proliferation assay services, employing a variety of techniques tailored to meet diverse research needs.

KATO III Cells

The KATO III cell line, derived from a human gastric carcinoma, is a key model in cancer research, particularly in studying gastric cancer mechanisms and screening potential therapeutics. Originating from a 55-year-old Japanese patient's metastatic gastric adenocarcinoma, these cells exhibit characteristics highly similar to those of primary tumor cells. This makes KATO III cells indispensable not only for understanding the molecular underpinnings of gastric cancer but also for testing the efficacy and toxicity of therapeutic compounds. Their ability to proliferate rapidly and adapt to various experimental conditions provides a robust platform for high-throughput screening and mechanistic studies in drug development.

KATO III Cell-based Proliferation Assay Service

At Creative Biolabs, we offer comprehensive KATO III-based proliferation assay services designed to provide you with precise, reproducible results that will enhance your research outcomes. Our service portfolio includes various methods to measure cellular proliferation, such as MTT/XTT assay, BrdU incorporation assay, and CFSE-based flow cytometry assay, etc.

MTT assays measure cellular metabolic activity as an indirect marker of cell proliferation, providing a colorimetric readout that quantifies viable cell numbers. BrdU incorporation assays offer a direct assessment of DNA synthesis, highlighting actively proliferating cells. Flow cytometry-based cell cycle analysis enables detailed examination of cell cycle distribution, revealing the proliferative status of the tested cells. By employing these diverse techniques, Creative Biolabs ensures that each project is tailored to meet your specific research needs.

Upon completion of the assay, you will receive a detailed data package that includes the original experimental data, meticulous analysis results, a step-by-step experimental flow, and a comprehensive report. Our analysis results encompass critical metrics such as dose-response curves and IC50 values, providing you with clear insights into the efficacy of your compounds. This robust data delivery allows you to make informed decisions about the potential therapeutic value of your investigational drugs and molecules.

Advantages

• Diverse cell proliferation assays are available
• Customized solutions
• Expertise and reliability
• Comprehensive data delivery
• Rapid turnaround time

Comprehensive Tumor Cell Proliferation Assay Services

Creative Biolabs offers proliferation assays on various other tumor cell lines, providing a versatile platform for exploring the effects of therapeutic agents across different cancer types. Whether you are investigating breast cancer, lung cancer, or any other malignancies, our proliferation assays can be tailored to suit your specific research needs. By expanding our services to cover multiple tumor cell lines, we aim to support a broader range of oncology research and contribute to the discovery of novel and effective cancer therapies. Contact us today to learn more about our proliferation assay services and how we can support your cancer research and therapeutics development.

For Research Use Only | Not For Clinical Use